Clinical Trials Sponsored by Biovest International

Total 6222 results

Biovest International

Unknown

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma (BiovaxID)

Non-Hodgkins Lymphoma
BioVex Limited
Symbion Research International

Completed

A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

Melanoma

United Kingdom, United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma

United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Biotest

Completed

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis Vulgaris

Czech Republic, Hungary
Biotest

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) (ESsCAPE)

Community-acquired Pneumonia

Australia, Spain, Israel, France, Brazil, United Kingdom, United States, Germany, Philippines, Belgium, Romania, Czechia, Hungary, Austria, Argentina, South Africa, New Zealand
Biotest

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

COVID-19 | Pneumonia | Acute Respiratory Distress Syndrome | Community-acquired Pneumonia | Respiratory Infection | Bacterial Pneumonia | Viral Pneumonia | Fungal Pneumonia

Belgium, Brazil, Latvia, Germany, Lithuania, South Africa, Argentina, Austria, France, Hungary, Slovakia, Turkey, Portugal, Spain
Biotest

Active, not recruiting

Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) (PreCyssion)

Congenital Cytomegalovirus Infection

Germany
Biotest

Completed

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 (ESsCOVID)

Covid19

Brazil, France, Russian Federation, Spain
Biotest

Completed

Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus (BT063 in SLE)

Systemic Lupus Erythematosus

Belarus, Georgia, Poland, Serbia
Biotest

Completed

Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP (CIGMA)

Community Acquired Pneumonia

Germany, Belgium, Spain, United Kingdom
Biotest

Completed

Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

Rheumatoid Arthritis

Poland, Czech Republic, Germany, Hungary, Italy, Latvia, Spain
BIOrest Ltd.

Unknown

BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (BLADE)

Diabetes Mellitus

Israel
Biotest
AbbVie

Terminated

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis (986)

Rheumatoid Arthritis

United States, Bulgaria, Canada, Czechia, Estonia, Germany, Hungary, Lithuania, Mexico, Poland, Russian Federation, Serbia, Slovakia, Ukraine
Bioness Inc
Bioness Neuromodulation

Completed

Evaluation of the Safety and Performance of the NESS L300 Plus System (L300Plus)

Foot Drop | Thigh Muscles Weakness (Hamstrings or Quadriceps) | Upper Motor Neuron Injury or Disease

Israel
Biotest Pharmaceuticals Corporation

Withdrawn

Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)

Hepatitis B, Chronic
BioWest Therapeutics Inc

Unknown

A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Chronic Hepatitis C

Canada
BioWest Therapeutics Inc

Completed

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic

Canada
BioWest Therapeutics Inc

Completed

A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic

Canada
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
BioWest Therapeutics Inc

Completed

A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic
US Biotest, Inc.

Terminated

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

SARS-CoV-2 Infection | Respiratory Distress Syndrome, Adult | Adult Respiratory Distress Syndrome | COVID-19 Virus Infection | SARS Coronavirus 2 Infection | 2019 Novel Coronavirus Infection

United States
Biotest
Syneos Health

Completed

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Primary Immunodeficiency Disease

United States, Germany, Hungary, Russian Federation, Spain
Biotest
Syneos Health

Completed

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Bulgaria, Czechia, Germany, Hungary, Serbia, Spain
Biotest Pharmaceuticals Corporation

Completed

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation

Hepatitis B Virus Associated Liver Disease

United States
Biotest Pharmaceuticals Corporation

Completed

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Liver Cirrhosis | Hepatitis, Viral, Human | Hepatocellular Carcinoma | Hepatitis C Infection | Viruses

United States
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

Sepsis | Fungemia | Bacteremia

United States
Biolert

Completed

Study of Algorithm for Epilepsy Alert Device

Motor Seizures
University Hospital, Lille
Biotest

Recruiting

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. (CMV-GVHD)

Cytomegalovirus Infections

France
RWTH Aachen University
Biotest

Recruiting

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (PEPPER Trial). (PEPPER)

Sepsis | Septic Shock | Peritonitis

Austria, Germany
Hannover Medical School
Biotest

Recruiting

Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins (HBIG)

Chronic Hepatitis B

Germany
Biotest
PRA Health Sciences

Completed

Adjusted Fibrinogen Replacement Strategy (AdFIrst)

Bleeding Disorder | Hypofibrinogenemia; Acquired

Belgium, Czechia, Germany, Poland, Spain, Switzerland, United Kingdom
Institut de Recherches Internationales Servier
Breast International Group

Completed

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (FINESSE)

Breast Cancer

United Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
University Hospital, Bordeaux
Biotest

Recruiting

Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection (SYNTAGME)

Kidney Transplantation | CMV Infection

France
Bioness Neuromodulation
Loewenstein Hospital; Bioness Inc

Unknown

Evaluation of Usability and Human Factors in the Novus System

Muscle Weakness | Motor Neuron Disease, Upper | Drop Foot

Israel
Bioness Inc

Recruiting

StimRouter Registry Clinical Protocol

Nervous System Diseases | Chronic Pain | Peripheral Nervous System Diseases | Peripheral Neuropathy | Peripheral Nerve Injuries | Peripheral Nervous System Problem | Peripheral Nervous

United States
Bioness Inc

Unknown

Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial

Overactive Bladder

United States, Canada
Bioness Inc

Terminated

StimRouter™ for Pain Management in Post-stroke Shoulder Pain (PSSP)

Chronic Pain | Hemiplegic Shoulder Pain

United States
Bioness Inc

Completed

Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves (StimRouter)

Unilateral Carpal Tunnel Syndrome

United States
Bioness Inc

Completed

Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy

Chronic Pain

United States
Bioness Inc

Completed

An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects (BBPM)

Shoulder Pain Chronic

United States
Biomet Orthopedics, LLC

Withdrawn

A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the Copeland™ Humeral Resurfacing Head

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Humeral Fractures
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a-Magnum™ Hip System

Arthritis | Rheumatoid Arthritis | Osteoarthritis, Hip | Joint Disease | Bone Disease
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the M2a- 38™ Hip System

Osteoarthritis | Avascular Necrosis | Non-inflammatory Degenerative Joint Disease
Biomet Orthopedics, LLC

Terminated

A Clinical Investigation of the Oxford® Partial Knee System

Osteoarthritis
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

Femoral Neck Fractures

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

ReCap Total Hip Resurfacing Prospective Data Collection

Arthritis

United Kingdom

Clinical Trials Sponsored by Biovest International

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations